Sigyn Therapeutics, Inc. SIGY
Set alert
0.03 USD 0.00 -7.33%
At close · Oct 30
0.0278 Day range 0.0303
0.01 52-week range 2.00
- YTD
- -98.37%
- 1 year
- -98.61%
- Open
- 0.0303
- Prev close
- 0.03
- Mkt cap
- 150.10K
- Vol
- 2.00K
- Avg vol
- 9.77K
- EPS
- -1.93
- P/E
- 0.00
More statistics
- Low
- 0.0278
- High
- 0.0303
2Y chart
Events in this range
- Nov 19, 2024Earnings: -0.94; estimate 0; surprise —%
Signals (70)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 27, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 29, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
Newest 20 of 70.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 19, 2024 | Sep 1, 2024 | 0.00 | -0.94 | — | — |
| Aug 19, 2024 | Jun 1, 2024 | 0.00 | -0.70 | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | -0.62 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -0.80 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -0.80 | — | — |
| May 16, 2023 | Mar 1, 2023 | 0.00 | -1.20 | — | — |
News
- Oragenics Signs LOI To License Certain Disease Indications Of CardioDialysis, Blood Purification Technology, From Sigyn Therapeutics
- Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
- Head-To-Head Analysis: Sigyn Therapeutics (OTCMKTS:SIGY) vs. Shuttle Pharmaceuticals (NASDAQ:SHPH)
- Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX
- Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX
- Sigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18th
- RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
- Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
- Sigyn Therapeutics to Present at Tomorrow's Small Cap Growth Virtual Investor Conference
- Sigyn Therapeutics™ to Present at Tomorrow's Emerging Growth Conference
Your note
Sign in to keep a note on SIGY — it syncs with the Stock Master app.